Welcome to the 6th Annual Allogeneic Cell Therapies Summit
Driving Potency, Efficacy & Durability of Universal Cell Therapies
The entire cell therapy field is experiencing a shift towards allogeneic platforms as the potential to achieve a truly off-the-shelf, universal, and efficacious cell therapy offers great advantages such as reduced cost, production and patient accessibility compared to its autologous counterparts.
Placing a spotlight on what has been deemed the ‘future of cell therapy’, the 6th Annual Allogeneic Cell Therapies Summit returns to Boston this June as the leading industry focused meeting dedicated to accelerating the safety, durability and clinical translation of off-the-shelf therapies to deliver affordable and accessible treatments for patients in critical need.
Across a jam-packed agenda consisting of 60+ hours of content, 3 in-depth tracks, 1 Investor & Business Development Focus Day, 1 Beyond Oncology Bootcamp Day and more; our 50+ expert speakers will lead you and your peers in discussions that will help to transform universal cell therapies for patients across the globe.
60+
Hours of Content
3
In-Depth Tracks
50+
Expert Speakers
2
New Pre-Conference Days
12+
New Speaking Companies
2
Conference
Days
Our World Class Speaker Faculty Includes:
Colleen Delaney
Founder & Chief Scientific Officer, Executive Vice President - Research & Development
Deverra Therapeutics
"The networking opportunities are great. I get the chance to talk to many people in this field and get to know some key players. Talks are relevant and informative”
Stemcell Technologies